Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SYP antisense RNA 1 (SYP-AS1) is a long non-coding RNA (lncRNA) gene located on the X chromosome. It does not encode a protein, but is involved in the regulation of synapse formation and neuronal development, likely through mechanisms that include modulation of gene expression, interaction with microRNAs, or transcriptional regulation of target genes. The precise molecular mechanisms by which SYP-AS1 functions are still being investigated[1]. There is no evidence that SYP-AS1 functions as a classical therapeutic target, such as a receptor, enzyme, or transporter, nor are there known drugs that interact with it or mechanisms of drug action specifically targeting it[1][3]. Additional context: Antisense lncRNAs generally regulate gene expression via epigenetic, transcriptional, or post-transcriptional mechanisms. Their dysregulation can potentially contribute to disease, but SYP-AS1 does not currently have a defined therapeutic or biomarker role[2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SYP antisense RNA 1 (SYP-AS1).